Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 6541 AL 6555

Huntington's disease-like 2 patients' profile in a Brazilian cohort

Boone DL, Tumas V, Vilela G, Borges V, Rodrigues Pinto RAS, Costa MC, Ferraz HB.

Parkinsonism Relat Disord. 2025 Oct;139:108023. doi: 10.1016/j.parkreldis.2025.108023. Epub 2025 Sep 3.

Melatonin for Huntington's Disease (HD) gene carriers with HD-related sleep disturbance - A pilot study

Zadegan SA, Karagas N, Tanigaki W, Duncan B, Dongarwar D, Patino J, Rocha NP, Furr Stimming E.

Sleep Med. 2025 May;129:238-244. doi: 10.1016/j.sleep.2025.02.032. Epub 2025 Mar 4.

Epidemiology and clinical features of Huntington's disease in MENASA region: A systematic review and meta-analysis

Salari M, Rezaei K, Hojjati Pour F, Sepehrnia M, Etemadifar M.

J Huntingtons Dis. 2025 Nov;14(4):319-330. doi: 10.1177/18796397251356620. Epub 2025 Jul 3.

Psychosis in Huntington's disease: A systematic review of case reports

Yakubu AO, Olalude OE, Anifalaje OK, Effiong MG, Adeyemi FO, Abubakar M.

Gen Hosp Psychiatry. 2025 Nov-Dec;97:82-93. doi: 10.1016/j.genhosppsych.2025.09.008. Epub 2025 Sep 26.

Cell Type-Specific Studies of Human Tissue for Investigation of the Molecular Cell Biology of Late-Onset Neurodegenerative Disease

Mätlik K, Pressl C, Heintz N.

Annu Rev Neurosci. 2025 Jul;48(1):277-295. doi: 10.1146/annurev-neuro-112723-025516. Epub 2025 Mar 18.

Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review

Lau BSR, Chua NYM, Ong WT, Singh H, Luvira V, Takaori K, Shelat VG.

Medicina (Kaunas). 2025 Feb 27;61(3):417. doi: 10.3390/medicina61030417.

High-Affinity, Structure-Validated and Selective Macrocyclic Peptide Tools for Chemical Biology Studies of Huntingtin

Wolf E, Fanti R, Ikenoue T, Deme JC, Balakrishnan S, Keith BA, Alteen MG, Chandrasekaran R, Yadav M, Bhajiawala R, Ackloo S, Feng J, Pouladi MA, Edwards AM, Wilson D, Lea SM, Suga H, Harding RJ.

bioRxiv [Preprint]. 2025 Aug 6:2025.08.06.668955. doi: 10.1101/2025.08.06.668955.

Microbiota dysbiosis impact on the immune system dysregulation in Huntington's disease (HD)

Acharjee P, Prasad SK, Singh VV, Ray M, Acharjee A.

Int Rev Neurobiol. 2025;180:57-94. doi: 10.1016/bs.irn.2025.04.002. Epub 2025 May 2.

Advances in research on mitochondrial dysfunction in neurodegenerative diseases

Zhang Y, Li XW, Zhang Y, Li X.

J Neurol. 2025 Apr 28;272(5):364. doi: 10.1007/s00415-025-13101-4.

Economic burden of Huntington's disease: A systematic review

Gokhale P, Villa Zapata L.

J Huntingtons Dis. 2025 Feb;14(1):30-42. doi: 10.1177/18796397251319209. Epub 2025 Feb 10.

The role of autophagy in the pathogenesis and treatment of multiple sclerosis

Righes G, Semenzato L, Koutsikos K, Zanato V, Pinton P, Giorgi C, Patergnani S.

Autophagy Rep. 2025 Jul 22;4(1):2529196. doi: 10.1080/27694127.2025.2529196. eCollection 2025.

Novel Thieno[3,2‑b]Pyridine Derivatives in the Treatment of Huntington's Disease

Zhao T, Liang SH.

ACS Med Chem Lett. 2025 Jul 30;16(8):1515-1516. doi: 10.1021/acsmedchemlett.5c00436. eCollection 2025 Aug 14.

Update on the Symptomatic Treatment of Huntington's Disease: From Pathophysiology to Clinical Practice

Olmedo-Saura G, Bernardi E, Bojtos L, Martínez-Horta S, Pagonabarraga J, Kulisevsky J, Pérez-Pérez J.

Int J Mol Sci. 2025 Jun 27;26(13):6220. doi: 10.3390/ijms26136220.

[Diagnosis and treatment dyskinesias in pediatrics]

Huerta Hurtado A, Zea Vera A.

Medicina (B Aires). 2025 Sep;85 Suppl 4:64-70.

Challenges in studying disparities in neuropsychiatric hyperkinetic movement disorders

Dy-Hollins ME, Mendizabal A, Tsai AC.

Curr Opin Neurol. 2025 Aug 1;38(4):343-348. doi: 10.1097/WCO.0000000000001379. Epub 2025 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias